Notify me when FARALLON PARTNERS L L C/CA files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | Common stock, par value $0.001 per share (the "Shares") | 10% | $119,266,365 | 13,461,215 | Dapice Joshua J. | 31 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|